Get In Touch
Have any questions or comments about the content you see on this page?
January 31, 2023
The publication of the 2023 Bloomberg Gender-Equality Index (GEI) marks Alnylam's third consecutive year of inclusion in this prestigious and important diversity, equity and inclusion (DE&I) benchmark. It also represents an opportunity for us to reflect on our progress in DE&I and assess our efforts using the rich set of data and insights that the GEI report provides.
Being recognized as part of the Bloomberg GEI for the third year in a row is exciting because it reflects our ongoing efforts to build a company that is truly committed to being diverse, equitable and inclusive. Our focus on ensuring that Alnylam is a workplace where women, and all employees, are supported, feel that they belong, and can thrive is core to our values and critical to our mission of bringing new treatments to patients living with rare and more common diseases." - Saraswathy (Sara) Nochur, Alnylam's Chief DE&I Officer
The GEI is published annually by Bloomberg - a globally recognized business and financial information and news leader, as a resource for investors. The Gender-Equality Index standardizes, measures and contextualizes workplace gender metrics data supplied to Bloomberg voluntarily by companies.
According to Bloomberg, "the GEI tracks the performance of public companies committed to disclosing their efforts to support gender equality through policy development, representation and transparency.”
Companies who submit for inclusion in the GEI (at no cost) use Bloomberg's standardized reporting framework. The GEI scoring methodology is comprised of two components: the amount of data disclosed and data excellence. According to Bloomberg, "Data excellence assesses a company’s performance against the key pillars of the GEI framework, in comparison with its industry peer group." Those five key pillars are:
There are also expanded areas of information requested to support the broader goal of providing more robust ESG (environmental, social, governance) data to investors.
Included companies are not ranked. The 2023 GEI consists of 484 companies, headquartered in 45 countries and regions, across 11 sectors and 54 industries. Alnylam was one of just 33 healthcare sector companies selected to this year's list. You can access the full list and Bloomberg's 2023 GEI Summary Report here.
The GEI serves as a touchstone for companies seeking to track their progress in gender inclusion and how the implementation of diversity policies shape company performance. A record number of companies disclosed their data for this year's GEI by using the GEI Framework, an increase of 11% year-over-year.
“This year, GEI members’ disclosure for exploratory questions averaged at 92%, demonstrating collective interest in extending beyond gender inclusion metrics,” said Patricia Torres, Global Head of Bloomberg Sustainable Finance Solutions at Bloomberg. “The GEI continues to identify areas of impact for companies, helping to facilitate meaningful change that, ultimately, will contribute to more innovation, creativity, and higher performance.”
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.Proceed to Site